Display options
Cite
Brown SC, Dauterive RL. Anticonvulsant hypersensitivity syndrome secondary to carbamazepine. Proc (Bayl Univ Med Cent). 2017;30(1):94-96doi: 10.1080/08998280.2017.11929545.
Brown, S. C., & Dauterive, R. L. (2017). Anticonvulsant hypersensitivity syndrome secondary to carbamazepine. Proceedings (Baylor University. Medical Center), 30(1), 94-96. https://doi.org/10.1080/08998280.2017.11929545
Brown, Shannon C, and Dauterive, Robin L. "Anticonvulsant hypersensitivity syndrome secondary to carbamazepine." Proceedings (Baylor University. Medical Center) vol. 30,1 (2017): 94-96. doi: https://doi.org/10.1080/08998280.2017.11929545
Brown SC, Dauterive RL. Anticonvulsant hypersensitivity syndrome secondary to carbamazepine. Proc (Bayl Univ Med Cent). 2017 Jan;30(1):94-96. doi: 10.1080/08998280.2017.11929545. PMID: 28127149; PMCID: PMC5242130.
Copy Download .nbib Format: NLM
Share it on

Proc (Bayl Univ Med Cent). 2017 Jan;30(1):94-96. doi: 10.1080/08998280.2017.11929545.

Anticonvulsant hypersensitivity syndrome secondary to carbamazepine.

Proceedings (Baylor University. Medical Center)

Shannon C Brown, Robin L Dauterive

Affiliations

  1. Department of Internal Medicine, Baylor Scott & White Hospital, Temple, Texas.

PMID: 28127149 PMCID: PMC5242130 DOI: 10.1080/08998280.2017.11929545

Abstract

Anticonvulsant hypersensitivity syndrome (AHS) is a potentially fatal multiorgan drug reaction that presents with various cutaneous eruptions. There is a genetic predisposition to such reactions. We present a young woman with AHS due to carbamazepine that presented as an atypical erythema multiforme with elevated liver enzymes.

References

  1. Expert Opin Drug Saf. 2012 Sep;11(5):767-78 - PubMed
  2. J Pharmacol Pharmacother. 2014 Jan;5(1):59-62 - PubMed

Publication Types